Chemoimmunotherapeutic approach to prolonged survival time in combination with immunization and glutamic acid derivatives with antitumor activity in tumor-bearing mice

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 12, 2007, Pages 2334-2339

  Samanta, Soma ^a   Alam, S K Mahasin ^a   Basu, Soumya ^a   Maji, Tapas ^b   Roy, Dilip Kumar ^b   Jha, Tarun ^a  

^a JADAVPUR UNIVERSITY   (India)

^b CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

Author keywords

Cancer; Chemoimmunotherapy; Glutamine; Survival time; Swiss Albino mouse

Indexed keywords

1,5 N,N' DI BUTYL 2 (2',4' DIMETHYLBENZENESULPHONYL)GLUTAMMAMIDE; 1,5 N,N' DI ISOBUTYL 2 (2',5' DICHLOROBENZENESULPHONYL)GLUTAMMAMIDE; 2 (BENZENESULPHONYL)ISOGLUTAMINE; 5 N C HEXYL 2 (2',4' DIMETHYLBENZENESULPHONYL)GLUTAMINE; 5 N HEXYL 2 (4' ISOBUTYLBENZENESULPHONYL)GLUTAMINE; ETOPOSIDE; GLUTAMIC ACID DERIVATIVE; TUMOR EXTRACT; TUMOR VACCINE; UNCLASSIFIED DRUG; WHOLE CELL VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CELL THERAPY; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; EHRLICH ASCITES TUMOR; FEMALE; HUMAN; HUMAN CELL; MONOTHERAPY; MOUSE; NONHUMAN; SURVIVAL TIME; TREATMENT OUTCOME;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CANCER VACCINES; CARCINOMA, EHRLICH TUMOR; COMBINED MODALITY THERAPY; ETOPOSIDE; FEMALE; GLUTAMATES; IMMUNIZATION; IMMUNOTHERAPY; MICE; STRUCTURE-ACTIVITY RELATIONSHIP; SURVIVAL ANALYSIS; TISSUE EXTRACTS;

EID: 36849073661     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.2334     Document Type: Article

References (24)

1. Zagozdzon R., Golab J., Stoklosa T., Giermasz A., Nowicka D., Feleszko W., Lasek W., Jakobisiak M., Int. J. Cancer, 77, 720-727 (1998).
2. Kedar E., Rutkowski Y., Leshem B., Cancer Immunol. Immunother., 35, 63-68 (1992).
3. Nowak A. K., Lake R. A., Robinson B. W., Adv. Drug Deliv. Rev., 58, 975-990 (2006).
4. Sinkovics J. G., Horvath J. C., Int. J. Oncol., 29, 765-777 (2006).
5. Cheuk A. T., Chan L., Czepulkowski B., Berger S. A., Yagita H., Okumura K., Farzaneh F., Mufti G. J., Guinn B., Cancer Immunol. Immunother., 55, 68-75 (2005).
6. Nair S. K., Snyder D., Rouse B. T., Gilboa E., Int. J. Cancer, 70, 706-715 (1997).
7. Srikanth K., Debnath B., Jha T., Bioorg. Med. Chem., 10, 1841-1854 (2002).
8. Srikanth K., Kumar C. A., Ghosh B., Jha T., Bioorg. Med. Chem., 10, 2119-2131 (2002).
9. Srikanth K., Debnath B., Nayak S. S., Jha T., Indian J. Pharmacol., 34, 172-177 (2002).
10. Debnath B., Srikanth K., Banerjee S., Jha T., Internet Electron. J. Mol. Des., 1, 488-502 (2002).
11. Samanta S., Srikanth K., Banarjee S., Debnath B., Gayen S., Jha T., Bioorg. Med. Chem., 12, 1413-1423 (2004).
12. Gayen S., Debnath B., Samanta S., Ghosh B., Basu A., Jha T., Internet Electron. J. Mol. Des., 4, 556-578 (2005).
13. Debnath B., Samanta S., Gayen S., Basu A., Ghosh B., Jha T., Internet Electron. J. Mol. Des., 4, 393-412 (2005), www.biochempress.com.
14. Debnath B., Gayen S., Samanta S., Basu A., Ghosh B., Jha T., Indian J. Chem. A, 45A, 93-99 (2006).
15. Debnath B., Ph.D. Thesis, Jadavpur University, 2004.
16. Samanta S., Ph.D. Thesis, Jadavpur University, 2007.
17. Fernandez N., Duffour M. T, Perricaudet M., Lotze M. T., Tursz T., Zitvogel L., Cytokines Cell. Mol. Ther., 4, 53-65 (1998).
18. Larionov L. F., "Cancer Chemotherapy," translated from the Russian by Crazy A., Pergamon Press, Oxford, 1965.
19. Shrayer D. P., Kouttab N., Hearing V. J., Wanebo H. J., Cancer Immunol. Immunother., 46, 7-13 (1998).
20. Forthofer R. N, Lee E. S., "Introduction to Biostatistics: A Guide to Design, Analysis and Discovery," Elsevier, New Delhi, 2006, pp. 283-285.
21. Bolton S., "Pharmaceutical Statistics: practical and clinical application," 3rd ed., Marcell Dekker Inc., New York, 1997.
22. Ehrke M. J., Verstovsek S., Krawczyk C. M., Ujhazy P., Zaleskis G., Maccubbin D. L., Mihich E., Int. J. Cancer, 63, 463-471 (1995).
23. Bass K. K., Mastrangelo M. J., Cancer Immunol. Immunother., 47, 1-12 (1998).
24. Hamuro J., Kikuchi M. T., Takatsuki F., Suzuki M., Br. J. Cancer, 73, 465-471 (1996).